A randomized, double blind, parallel-group, placebo controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500g birth weight in the prevention of necrotizing enterocolitis The Connection study

Project: Other project

Project Details

StatusActive
Effective start/end date10/24/1910/23/22

Funding

  • Infant Bacterial Therapeutics AB: $5,046.15